In this engaging conversation, Nataliya Andreychuk and Paul Tunnah discuss the evolving landscape of the pharmaceutical industry as they approach 2026. They explore the importance of digital transformation, emphasizing the need for a human-centric approach rather than a technology-first mindset.

The discussion delves into the risks and rewards associated with AI in pharma, the significance of customer engagement, and the challenges of hyper-personalization versus effective segmentation.

Takeaways

Digital transformation must prioritize human change over technology.

AI presents both risks and rewards that need careful consideration.

Customer engagement strategies should focus on building trust and connection.

Segmentation is crucial for effective communication in pharma.

Hyper-persona ...